HC Deb 03 March 1993 vol 220 c169W
Mr. Dalyell

To ask the Secretary of State for Health (1) what is the policy of national health service laboratories about entering into agreements to pay fees in respect of gene patents;

(2) what advice she is giving in response to patent claims in relation to biotechnology intellectual property, with particular references to the cystic fibrosis gene;

(3) what is her policy in relation to licence fees for the use of polymerase chain reactions.

Mr. Sackville

The subject of intellectual property rights, including those for polymerase chain reaction and gene sequences, is under review.